The prevalence of latent tuberculosis infection in the United States

American Journal of Respiratory and Critical Care Medicine

Volumn 194, Issue 4, 2016, Pages 501-509

  Mancuso, James D ^a   Diffenderfer, Jeffrey M ^a,b   Ghassemieh, Bijan J ^c   Horne, David J ^c,d   Kao, Tzu Cheg ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c Weill Cornell Medicine   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

IFN g release tests; Latent tuberculosis; Nutrition survey; Tuberculin test; Tuberculosis epidemiology

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOBACTERIUM TUBERCULOSIS TEST KIT; NUTRITION; PREVALENCE; PRIORITY JOURNAL; RELEASE ASSAY; TUBERCULIN TEST; TUBERCULOSIS CONTROL; UNITED STATES; AFRICAN AMERICAN; AGE DISTRIBUTION; ASIAN AMERICAN; CAUCASIAN; COMORBIDITY; ETHNOLOGY; HISPANIC; HIV INFECTIONS; MIDDLE AGED; MIGRANT; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGED; ASIAN AMERICANS; CHILD; COMORBIDITY; EMIGRANTS AND IMMIGRANTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; RISK ASSESSMENT; TUBERCULIN TEST; UNITED STATES; YOUNG ADULT;

EID: 84988935263     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201508-1683OC     Document Type: Article

References (42)

1. Scott C, Kirking HL, Jeffries C, Price SF, Pratt R; Centers for Disease Control and Prevention (CDC). Tuberculosis trends-United States, 2014. MMWR Morb Mortal Wkly Rep 2015;64: 265-269.
2. Division of Tuberculosis Elimination. Reported tuberculosis in the United States, 2013. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
3. Geiter L. Ending neglect: the elimination of tuberculosis in the United States. Washington, DC: National Academy Press; 2000.
4. Hill AN, Becerra J, Castro KG. Modelling tuberculosis trends in the USA. Epidemiol Infect 2012;140:1862-1872.
5. Ferebee SH. The epidemiological basis of tuberculosis control. Bull Natl Tuberc Assoc 1967;53:4-8.
6. Suwanpimolkul G, Jarlsberg LG, Grinsdale JA, Osmond D, Kawamura LM, Hopewell PC, Kato-Maeda M. Molecular epidemiology of tuberculosis in foreign-born persons living in San Francisco. Am J Respir Crit Care Med 2013;187:998-1006.
7. Ricks PM, Cain KP, Oeltmann JE, Kammerer JS, Moonan PK. Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009. PLoS One 2011;6:e27405.
8. Moonan PK, Ghosh S, Oeltmann JE, Kammerer JS, Cowan LS, Navin TR. Using genotyping and geospatial scanning to estimate recent mycobacterium tuberculosis transmission, United States. Emerg Infect Dis 2012;18:458-465.
9. Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh CR Jr. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol 2014;179:216-225.
10. Sloot R, Schim van der Loeff MF, Kouw PM, Borgdorff MW. Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. Am J Respir Crit Care Med 2014;190: 1044-1052.
11. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350: 2060-2067.
12. Taylor Z, Nolan CM, Blumberg HM, American Thoracic Society, Centers for Disease Control and, Prevention, Infectious Diseases Society of America. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005;54:1-81.
13. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, McQuillan GM, Lewis B, Navin TR, Castro KG. Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999-2000. Am J Respir Crit Care Med 2008;177:348-355.
14. National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) 2011-2012. [Accessed 2016 Feb 15]. Available from: http://wwwn.cdc.gov/Nchs/Nhanes/Search/nhanes11-12.aspx
15. National Center for Health Statistics. National Health and Nutrition Examination Survey: sample design, 2011-2014. [Accessed 2015 Jan 24]. Available from: http://www.cdc.gov/nchs/data/series/sr-02/sr02-162.pdf
16. Villarino ME, Burman W, Wang YC, Lundergan L, Catanzaro A, Bock N, Jones C, Nolan C. Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. JAMA 1999; 281:169-171.
17. National Center for Health Statistics. National Health and Nutrition Examination Survey: Tuberculosis skin test procedures manual. Atlanta, GA: CDC; 2001.
18. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161: 1376-1395.
19. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, Committee IE, Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010;59: 1-25.
20. Heeringa SG, West BT, Berglund PA. Applied survey data analysis. Boca Raton, FL: Taylor and Francis; 2010.
21. National Center for Health Statistics. National Health and Nutrition Examination Survey: analytic guidelines, 2011-2012. [2 May 2014; accessed 2016 Jan 13]. Available from: http://www.cdc.gov/nchs/data/nhanes/analytic-guidelines- 11-12.pdf
22. Miramontes R, Hill AN, Yelk Woodruff RS, Lambert LA, Navin TR, Castro KG, LoBue PA. Tuberculosis infection in the United States: prevalence estimates from the National Health and Nutrition Examination Survey, 2011-2012. PLoS One 2015;10: e0140881.
23. Khan K, Wang J, Hu W, Bierman A, Li Y, Gardam M. Tuberculosis infection in the United States: national trends over three decades. Am J Respir Crit Care Med 2008;177:455-460.
24. Grieco EM, Acosta YD, de la Cruz GP, Gambino C, Gryn T, Larsen LJ, Trevelyan EN, Walters NP. The foreign-born population in the United States: 2010. Washington, DC: US Census Bureau; 2012.
25. Migration Policy Institute. Largest US immigrant groups over time, 1960-present. [Accessed 2015 July 15]. Available from: http://www.migrationpolicy.org/programs/data-hub/us-immigration-trends#history
26. World Health Organization. Global tuberculosis report 2015. Geneva, Switzerland: World Health Organization; 2015.
27. Iqbal AZ, Leighton J, Anthony J, Knaup RC, Peters EB, Bailey TC. Cost-effectiveness of using Quantiferon Gold (QFT-G) versus tuberculin skin test (TST) among U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis. Public Health Nurs 2014;31: 144-152.
28. Shah M, DiPietro D, Greenbaum A, Ketemepi S, Martins-Evora M, Marsiglia V, Dorman SE. Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. PLoS One 2012;7:e36551.
29. Grinsdale JA, Ho CS, Banouvong H, Kawamura LM. Programmatic impact of using QuantiFERON-TB Gold in routine contact investigation activities. Int J Tuberc Lung Dis 2011;15: 1614-1620.
30. Walters JK, Sullivan AD. Impact of routine quantiferon testing on latent tuberculosis diagnosis and treatment in refugees in Multnomah County, Oregon, November 2009-October 2012. J Immigr Minor Health 2015;18:292-300.
31. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-184.
32. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-975.
33. Rose DN, Schechter CB, Adler JJ. Interpretation of the tuberculin skin test. J Gen Intern Med 1995;10:635-642.
34. Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, et al.; Tuberculosis Epidemiologic Studies Consortium. Interferon-7 release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2014;189:77-87.
35. McMullen SE, Pegues DA, Shofer FS, Sheller AC, Wiener EB. Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis. Clin Infect Dis 2014;58:1260-1266.
36. Winston CA, Navin TR. Birth cohort effect on latent tuberculosis infection prevalence, United States. BMC Infect Dis 2010;10:206.
37. Rieder HL, Chadha VK, Nagelkerke NJ, van Leth F, van der Werf MJ; KNCV Tuberculosis Foundation. Guidelines for conducting tuberculin skin test surveys in high-prevalence countries. Int J Tuberc Lung Dis 2011;15:S1-S25.
38. Dorken E, Grzybowski S, Allen EA. Significance of the tuberculin test in the elderly. Chest 1987;92:237-240.
39. Nisar M, Williams CS, Ashby D, Davies PD. Tuberculin testing in residential homes for the elderly. Thorax 1993;48:1257-1260.
40. Centers for Disease Control and Prevention (CDC). Notes from the field: tuberculosis cluster associated with homelessness-Duval County, Florida, 2004-2012. MMWR Morb Mortal Wkly Rep 2012;61: 539-540.
41. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999;159: 15-21.
42. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49:1-51.